MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$1,369K
EPS
-$0.05
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
-
-
0
-
General and administrative
2,279
2,171
3,145
2,546
Research and development
-
3,641
2,329
4,887
Impairment of acquired in-process research and development intangible assets
-
-
0
-
Research and development
-803
-
-
-
Total operating expenses
1,476
5,812
5,474
7,433
Loss from operations
-1,476
-5,812
-5,474
-7,433
Other income, net
203
405
210
961
Net loss
-1,273
-5,407
-5,264
-6,472
Other comprehensive gain foreign currency translation
-96
10
27
-1
Total comprehensive loss
-1,369
-5,397
-5,237
-6,473
Basic EPS
-0.05
-0.2
-0.197
-0.24
Diluted EPS
-0.05
-0.2
-0.197
-0.24
Basic Average Shares
26,718,507
26,585,258
26,650,276
26,585,258
Diluted Average Shares
26,718,507
26,585,258
26,650,276
26,585,258
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Total comprehensive
loss
-$1,369K
(94.44%↑ Y/Y)
Net loss
-$1,273K
(94.80%↑ Y/Y)
Other comprehensive
gain foreign...
-$96K
(37.25%↑ Y/Y)
Other income, net
$203K
(79.65%↑ Y/Y)
Loss from operations
-$1,476K
(93.99%↑ Y/Y)
Total operating
expenses
$1,476K
(-93.99%↓ Y/Y)
Research and development
-$803K
(-113.84%↓ Y/Y)
General and
administrative
$2,279K
(1.15%↑ Y/Y)
Buy us a coffee
Inmune Bio, Inc. (INMB)
Inmune Bio, Inc. (INMB)